regorafenib
bayer
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'regorafenib']
interesting poster at #asco22: #regorafenib + #folfirinox as frotline treatment in #ras mutated #mcrc, phasei/ii study. promising efficacy with manageable toxicity, most frequent ae is gr. 3. in dose-escalation stage. abstract: 3561 poster: 355
#meded
Independent and international experts in GI oncology supporting medical oncologists to give the best possible care to patients. Part of https://t.co/Y8pV8OaxOB